Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia
Titel:
Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia
Auteur:
Grammatico, S. Elia, L. Peluso, A.L. Pedace, L. Matarazzo, M. Vitale, A. Rago, A. Pane, F. FoĆ , R. Cimino, G.